Mometasone furoate/Nortriptyline Hydrochloride

莫米松糠酸酯/盐酸去甲替林

Report date: 2022/11/25 18:10:08

Base Information

Drug NameMometasone furoate/Nortriptyline Hydrochloride
Drug Alias Name莫米松糠酸酯盐酸去甲替林Nortriptyline Hydrochloride and Mometasone furoateMometasone/nortriptyline盐酸去甲替林莫米松糠酸酯Nortriptyline Hydrochloride/Mometasone furoate +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionMonoamine oxidase inhibitorsGlucocorticoid receptor agonists
TargetsMonoamine oxidaseGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsYes Nortriptyline HydrochlorideMometasone furoate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZalicus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZalicus Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasis

Other Information

ATC CodeN/A
Related LinksN/A